Geriatric Hospital of Nanjing Medical University
Nanjing, Jiangsu, 210009, China
Location status: Recruiting
NCT Number: NCT07786844
Urinary stone disease is globally prevalent with rising incidence and recurrence, imposing heavy socioeconomic burdens. Flexible ureteroscopy has advanced stone treatment. Single-use flexible ureteroscopes (su-fURS) combined with negative pressure ureteral access sheath (NPUAS), recommended by urology guidelines, improve surgical safety and stone-free rates and can treat stones ≤3 cm. However, su-fURS has poorer image quality, bleeding during lithotripsy may blur vision, frequently impairing efficiency and safety.
Norepinephrine (NE), a tyrosine-derived sympathomimetic amine, mainly activates α1 and β1 receptors. Doses above 3 μg/min trigger predominant α1-mediated vasoconstriction of arteries and veins. It can act on mucosal surfaces via irrigation fluid, making it favorable for initial hemostasis of injured mucosa. Firstly, this study aims to evaluate the efficacy and safety of low-concentration norepinephrine (NE) irrigation solution for hemostasis during lithotripsy performed with single-use flexible ureteroscope (su-fURS) combined with NPUAS, fifteen subjects will be enrolled in the study. Secondly, we explore the dose-effect relationships of four concentrations: 2 mg/3 L, 4 mg/3 L, 6 mg/3 L and 8 mg/3 L, and determine the optimal concentration by comprehensively evaluating hemostatic efficacy and safety. A total of 40 subjects will be enrolled, with 10 subjects in each concentration.
Interested in participating?
Request Info18 year–75 year
All sexes
Interventional
Phase 1 / Phase 2
Nanjing, Jiangsu, 210009, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Under identical operating conditions, the irrigation fluid was collected before and 3 minutes after treatment with 4 mg/3 L NE bitartrate irrigation fluid.
Collect irrigation fluid samples before and after norepinephrine irrigation treatment, and measure the hemoglobin concentration in the irrigation fluid.
Time frame: Periprocedural
After treatment with NE irrigation fluid. Systolic blood pressure was obtained from anesthesia records.
Time frame: Periprocedural
After treatment with NE irrigation fluid. Mean arterial pressure (MAP) was obtained from anesthesia records
Time frame: Periprocedural
After treatment with NE irrigation fluid. Heart rate (HR) was obtained from anesthesia records.
Time frame: From initiation of study intervention up to completion of surgical procedure (within-operative period)
The proportion of participants whose study intervention is prematurely terminated because of safety-related adverse events or safety concerns.
Time frame: From initiation of study intervention up to completion of surgical procedure (within-operative period)
Record the type, dosage, route, and duration of all concomitant medications administered to participants during the study, including medications for underlying diseases, peri-operative supportive drugs and rescue medications.
Time frame: From time of initial intervention through 8 hours post-procedure, assessed up to Post-operative Day 1
Incidence of all-cause adverse events occurring in participants after study, including peri-operative complications and post-operative adverse events.
Time frame: 1 day after surgical procedure
Proportion of participants achieving stone-free status, defined as no residual stones or residual stone fragments ≤2 mm on postoperative imaging examination.
Contact information is provided by the study sponsor or research team.
Geriatric Hospital of Nanjing Medical University
Other
Hemostasis and Safety Analysis of Norepinephrine Irrigation Fluid in Su-FURS Combined With NPUAS Lithotripsy. (Su-FURS: Single-use Flexible Ureteroscope, NPUAS: Negative Pressure Ureteral Access Sheath)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06330246
Calculi, Female Urogenital Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT06331546
Calculi, Female Urogenital Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT06989320
Calculi, Female Urogenital Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT07763613
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Trabzon, Turkey (Türkiye)
View Trial Details